Low vitamin D among HIV-infected adults: Prevalence of and risk factors for low vitamin D levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the us general population

Clinical Infectious Diseases

Volumn 52, Issue 3, 2011, Pages 396-405

  Dao, Christine N ^a   Patel, Pragna ^a   Overton, E Turner ^b   Rhame, Frank ^c   Pals, Sherri L ^a   Johnson, Christopher ^a   Bush, Timothy ^a   Brooks, John T ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ABBOTT NORTHWESTERN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; EFAVIRENZ; RITONAVIR;

ADULT; AGE; ARTICLE; BODY MASS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ETHNICITY; EXERCISE; FEMALE; GENDER; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEGRO; OBSERVATIONAL STUDY; POPULATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; RISK FACTOR; ULTRAVIOLET RADIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SERUM; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79951817556     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq158     Document Type: Article

References (49)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
2. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;169:626-32.
3. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008;88:1519-27.
4. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005;16:83-95. (Pubitemid 40691207)
5. Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States. Arch Intern Med 2007;167:1159-65.
6. Forman J, Giovannucci E, Holmes M, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49:1063-9. (Pubitemid 351664326)
7. Bouillon R. Vitamin D: from photosynthesis, metabolism, and action to clinical applications. In: DeGroot LJ, Jameson JL eds: Endocrinology, 4th ed. Vol 2. Philadelphia, PA: WB Saunders, 2001:1009-28.
8. Food and Nutrition Board IoM. 1997 dietary reference intakes for calcium, magnesium, phosphorus, vitamin D, and fluoride. Washington, DC: National Academy Press, 2009.
9. Chapuy M-C, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997;7:439-43. (Pubitemid 27443069)
10. Heaney R, Dowell M, Hale C, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003;22:142-6. (Pubitemid 36417827)
11. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713-6. (Pubitemid 40933586)
12. Office of Dietary Supplements NIoH. Dietary supplement fact sheet: vitamin D. Available at: http://ods.od.nih.gov/factsheets/vitamind.asp. Accessed 10 December 2009.
13. Palella F, Delaney K, Moorman A, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60. (Pubitemid 28135961)
14. Onen N, Agbebi A, Shacham E, Stamm K, Onen A, Overton E. Frailty among HIV-infected persons in an urban outpatient care setting. J Infect 2009;59:346-52.
15. Goulet J, Fultz S, Rimland D, et al. Do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis 2007;45:1593-601. (Pubitemid 351411845)
16. Brown T, Qaqish R. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006;20:2165-74. (Pubitemid 44684707)
17. Triant V, Lee H, Hadigan C, Grinspoon S. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus diseases. J Clin Endocrinol Metab 2007;92:2506-12. (Pubitemid 47037350)
18. Shardell M, Hicks G, Miller R, et al. Association of low vitamin D levels with the frailty syndrome in men and women. J Gerontol A Biol Sci Med Sci 2009;64:69-75.
19. Chiu K, Chu A, Go V, Saad M. Hypovitaminosis D is associated with insulin resistance and B dysfunction. Am J Clin Nutr 2004;79:820-5. (Pubitemid 41103882)
20. Llewellyn D, Langa K, Lang I. Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 2009;22:188-95.
21. Mehta S, Spiegelman D, Magusi F, Giovannucci E, Msmanga G, Fawzi W. Vitamin D HIV-related complications and HIV disease progression women in Tanzania. In: Program and abstracts of the 17th Conference on Retroviruses and Opportunistic infections (San Francisco, CA). 2010.
22. Bolland MJ, Grey A, Horne AM, Thomas MG. Osteomalacia in an HIV-infected man receiving rifabutin, a cytochrome P450 enzyme induce: a case report. Ann Clin Microbiol Antimicrobials 2008;7:3.
23. Haug C, Muller F, Aukrust P, Froland SS. Subnormal serum concentration of 1, 25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. J Infect Dis 1997;169:889-93.
24. Rodriguez M, Daniels B, Gunawardene S, Robbins GK. High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses 2009;25:9-14.
25. Madeddu G, Spanu A, Solinas P, et al. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging 2004;48:39-48. (Pubitemid 39069663)
26. Mueller N, Fux C, Ledergerber B, et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010;24:1127-34.
27. Gyllensten K, Josephson F, Lidman K, Saaf M. Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59N. AIDS 2006;20:1906-7. (Pubitemid 44358915)
28. Fabbriciani G, De Socio GV. Efavirenz and bone health. AIDS 2009;23:1181.
29. Villamor E. A potential role for vitamin D on HIV infection? Nutr Rev 2006;64:226-33. (Pubitemid 43953286)
30. Van den Bout-Van den Beukel CJP, Fievez L, Michels M, et al. Vitamin D deficiency among HIV Type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008;24:1375-82.
31. Vellozzi C, Brooks JT, Bush TJ, et al. The study to understand the natural history of HIV and AIDS in the era of effective therapy (SUN study). Am J Epidemiol 2009;169:642-52.
32. NOAA, National Weather Service Climate Prediction Center. UV index: annual time series. Available at: http://www.cpc.ncep. noaa.gov/products/ stratosphere/uv-index/uv-annual.shtml. Accessed 9 October 2009.
33. National Center for Health Statistics, Centers for Disease Control and Prevention. National health and nutrition examination survey. Available at: http://www.cdc.gov/nchs/nhanes/about-nhanes.htm. Accessed 17 February 2009.
34. National Center for Health Statistics, Centers for Disease Control and Prevention. NHANES analytic guidelines. Available at: http://www.cdc.gov/nchs/ data/nhanes/nhanes-general-guidelines-june-04.pdf. Accessed 17 February 2009.
35. Hosmer D, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley, 2000.
36. Stephensen CB, Marquis GS, Kruzich LA, Douglas SD, Aldrovandi GM, Wilson CM. Vitamin D status in adolescents and young adults with HIV infection. Am J Clin Nutr 2006;83:1135-41. (Pubitemid 44713115)
37. Bischoff-Ferrari H, Giovannucci E, Willett W, Dietrick T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28. (Pubitemid 44699167)
38. Herzmann C, Arasteh K. Efavirenz-induced osteomalacia. AIDS 2009;23:274-5.
39. Welz T, Childs K, Ibrahim F, Poulton M, Post F. Efavirenz use is associated with severe vitamin D deficiency in a large, ethnically diverse urban UK HIV cohort. In: Program abstracts of the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (Cape Town, South Africa). 2009.
40. Brown T, McComsey G. Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther 2009;14(Suppl 2): A15.
41. Lattuada E, Lanzafame M, Zoppini G, Concia E, Vento S. No influence of nevirapine on vitamin D deficiency in HIV-infected patients. AIDS Res Hum Retroviruses 2009;25:849-50.
42. Valsamis HA, Surender KA, Labban B, McFarlane SI. Antiepileptic drugs and bone metabolism. Nutr Metab 2006;3:36.
43. Cozzolino M, Vidal M, Vittoria Arcidiacono M, Tebas P, Yarasheski KE, Dusso AS. HIV-protease inhibitors impair vitamin D bioactivation to 1, 25-dihydroxyvitamin D. AIDS 2003;17:513-20. (Pubitemid 36293104)
44. Woodward C, Hall A, William I, et al. Tenofovir-associated renal and bone toxicity. HIV Med 2009;10:482-7.
45. Peyriere H, Reynes J, Rouanet I, et al. Renal tubular dysfunction associated with tenofovir therapy. J Acquir Immune Defic Syndr 2004;35:269-73. (Pubitemid 38280652)
46. Horberg M, Tang B, Towner W, et al. Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr 2010;53:62-9.
47. Haug C, Muller F, Aukrust P, Froland SS. Subnormal serum concentration of 1, 25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. J Infect Dis 1994;169:889-93. (Pubitemid 24102128)
48. Childs K, Fishman S, Bateman K, et al. Should vitamin D be prescribed with tenofovir/FTC? In: Program and abstracts of the 48th Annual Interscience Conference on Antimicrobial Agents and Chenotherapy/Infectious Disease Society of America 46th Annual Meeting (Washington, DC). 2008.
49. Childs K, Fishman S, Factor S, Dieterich D, Mullen M, Branch A. First report of dose/response data of HIV-infected men treated with vitamin D3 supplements. In: Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections (Montreal, Canada). 2009.